231 related articles for article (PubMed ID: 23881279)
1. Plakophilin-associated RNA-binding proteins in prostate cancer and their implications in tumor progression and metastasis.
Yang C; Ströbel P; Marx A; Hofmann I
Virchows Arch; 2013 Sep; 463(3):379-90. PubMed ID: 23881279
[TBL] [Abstract][Full Text] [Related]
2. Plakophilins 1 and 3 bind to FXR1 and thereby influence the mRNA stability of desmosomal proteins.
Fischer-Kešo R; Breuninger S; Hofmann S; Henn M; Röhrig T; Ströbel P; Stoecklin G; Hofmann I
Mol Cell Biol; 2014 Dec; 34(23):4244-56. PubMed ID: 25225333
[TBL] [Abstract][Full Text] [Related]
3. Identification of the junctional plaque protein plakophilin 3 in cytoplasmic particles containing RNA-binding proteins and the recruitment of plakophilins 1 and 3 to stress granules.
Hofmann I; Casella M; Schnölzer M; Schlechter T; Spring H; Franke WW
Mol Biol Cell; 2006 Mar; 17(3):1388-98. PubMed ID: 16407409
[TBL] [Abstract][Full Text] [Related]
4. Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression.
Yang C; Fischer-Kešo R; Schlechter T; Ströbel P; Marx A; Hofmann I
Tumour Biol; 2015 Dec; 36(12):9567-77. PubMed ID: 26138584
[TBL] [Abstract][Full Text] [Related]
5. Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: implications for diagnosis and tumor progression.
Breuninger S; Reidenbach S; Sauer CG; Ströbel P; Pfitzenmaier J; Trojan L; Hofmann I
Am J Pathol; 2010 May; 176(5):2509-19. PubMed ID: 20348237
[TBL] [Abstract][Full Text] [Related]
6. Plakophilin 1 deficiency in prostatic tumours is correlated with immune cell recruitment and controls the up-regulation of cytokine expression post-transcriptionally.
Kim M; Reidenbach S; Schlechter T; Rothmann AC; Will R; Hofmann I
FEBS J; 2023 Apr; 290(7):1907-1919. PubMed ID: 36380691
[TBL] [Abstract][Full Text] [Related]
7. Complementary analysis of proteome-wide proteomics reveals changes in RNA binding protein-profiles during prostate cancer progression.
Aikio E; Koivukoski S; Kallio E; Sadeesh N; Niskanen EA; Latonen L
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1886. PubMed ID: 37591798
[TBL] [Abstract][Full Text] [Related]
8. G3BP is overexpressed in human tumors and promotes S phase entry.
Guitard E; Parker F; Millon R; Abecassis J; Tocqué B
Cancer Lett; 2001 Jan; 162(2):213-21. PubMed ID: 11146228
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding protein FXR1 modulates prostate cancer progression by regulating FBXO4.
Cao H; Gao R; Yu C; Chen L; Feng Y
Funct Integr Genomics; 2019 May; 19(3):487-496. PubMed ID: 30746571
[TBL] [Abstract][Full Text] [Related]
10. Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
Wang HZ; Wang F; Chen PF; Zhang M; Yu MX; Wang HL; Zhao Q; Liu J
Biomed Pharmacother; 2019 Mar; 111():1234-1242. PubMed ID: 30841437
[TBL] [Abstract][Full Text] [Related]
11. Expression of plakophilins (PKP1, PKP2, and PKP3) in gastric cancers.
Demirag GG; Sullu Y; Gurgenyatagi D; Okumus NO; Yucel I
Diagn Pathol; 2011 Jan; 6():1. PubMed ID: 21194493
[TBL] [Abstract][Full Text] [Related]
12. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
13. Plakophilin 1 is methylated and has a tumor suppressive activity in human lung cancer.
Haase D; Cui T; Yang L; Ma Y; Liu H; Theis B; Petersen I; Chen Y
Exp Mol Pathol; 2019 Jun; 108():73-79. PubMed ID: 30946843
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters.
Papagerakis S; Shabana AH; Depondt J; Gehanno P; Forest N
Hum Pathol; 2003 Jun; 34(6):565-72. PubMed ID: 12827610
[TBL] [Abstract][Full Text] [Related]
15. FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA.
Deng M; Wang N; Li Z; Chen R; Duan J; Peng Y; Wu Z; Zhang Z; Jiang L; Zheng X; Xie D; Wei W; Liu Z; Zhou F
Cell Death Dis; 2022 Feb; 13(2):170. PubMed ID: 35194031
[TBL] [Abstract][Full Text] [Related]
16. c-Src mediated tyrosine phosphorylation of plakophilin 3 as a new mechanism to control desmosome composition in cells exposed to oxidative stress.
Neuber S; Jäger S; Meyer M; Wischmann V; Koch PJ; Moll R; Schmidt A
Cell Tissue Res; 2015 Mar; 359(3):799-816. PubMed ID: 25501895
[TBL] [Abstract][Full Text] [Related]
17. CEP63 upregulates YAP1 to promote colorectal cancer progression through stabilizing RNA binding protein FXR1.
Ling H; Cao CH; Han K; Lv YR; Ma XD; Cao JH; Chen JW; Li S; Lin JL; Fang YJ; Pan ZZ; Xie D; Wang FW
Oncogene; 2022 Sep; 41(39):4433-4445. PubMed ID: 35989368
[TBL] [Abstract][Full Text] [Related]
18. Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers.
Demirag GG; Sullu Y; Yucel I
Med Oncol; 2012 Sep; 29(3):1518-22. PubMed ID: 21947748
[TBL] [Abstract][Full Text] [Related]
19. The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1.
Li L; Geng Y; Feng R; Zhu Q; Miao B; Cao J; Fei S
Cell Physiol Biochem; 2017; 42(6):2194-2206. PubMed ID: 28942451
[TBL] [Abstract][Full Text] [Related]
20. Single-molecule imaging reveals dynamic biphasic partition of RNA-binding proteins in stress granules.
Niewidok B; Igaev M; Pereira da Graca A; Strassner A; Lenzen C; Richter CP; Piehler J; Kurre R; Brandt R
J Cell Biol; 2018 Apr; 217(4):1303-1318. PubMed ID: 29463567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
